ADMA BIOLOGICS, INC.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-12-31

Reported

2026-02-25

Disclosure lag

56 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	ADMA BIOLOGICS, INC.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001368514/2026-07-26
Event ID	#29229

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001140361-26-006815",
  "canonical_covered": 12,
  "canonical_total": 12,
  "fiscal_period": "FY",
  "fiscal_year": 2025,
  "form": "10-K",
  "mapped_tag_share": 0.03811659192825112,
  "metrics": {
    "cash_and_equivalents": 87630000,
    "earnings_per_share_basic": 0.62,
    "earnings_per_share_diluted": 0.6,
    "gross_profit": 292765000,
    "net_income": 146930000,
    "operating_cash_flow": 50396000,
    "operating_income": 191443000,
    "revenue": 510173000,
    "shareholders_equity": 477320000,
    "shares_outstanding": 237874496,
    "total_assets": 624242000,
    "total_liabilities": 146922000
  },
  "metrics_reported": 12,
  "period_end": "2025-12-31"
}

Source: SEC EDGAR · as of 2026-02-25T00:00:00Z